Posts Tagged ‘Colorectal Cancer’

Tuesday July 19th, 2016

Hospital Clínic makes a commitment to the molecular diagnostic of solid tumors in clinical practice

Hospital Clínic de Barcelona goes one step forward in the molecular diagnosis of solid tumors with a single test that detects multiple mutations within 22 genes in patients with advanced lung cancer, melanoma and colorectal cancer. The implementation of this genetic test based on massive parallel sequencing technologies allows shortening the time of diagnosis and personalizing the treatment for each patient. With this test, the Medical Oncology department at Hospital Clínic, together with the Biomedical Diagnostic Center (CDB), positions at the forefront of the clinical application of this diagnostic tool in the Spanish public health system, because of the technology used and the number of genes and tumors analyzed.

Read the rest of this entry »

Comments Closed

Categories

Posted in:

Tuesday October 27th, 2015

International experts discuss about the importance of screening programs in the fight against colorectal cancer

International experts meet from 24 to 28 October in Barcelona at the European Congress of Gastroenterology (United European Gastroenterology Week) to discuss about the latest advances in research, diagnosis and treatment of digestive diseases. Special emphasis is placed on the fight against colorectal cancer, since, according to experts, Spain is lagging behind due to low deposit rates in screening programs. Dr. Antoni Castells, head of the Institute of Digestive and Metabolic Diseases (ICMDM) at Hospital Clinic of Barcelona, has been appointed United European Gastroenterology spokesperson on colorectal cancer screening programmes and is presenting today the results of his research in this field.

Read the rest of this entry »

Comments Closed
Monday September 28th, 2015

A study defines the risk of colon cancer in patients with serrated polyposis

A study led by researchers from Hospital Clínic and IDIBAPS defines more precisely the risk of developing colon cancer in patients with serrated polyposis, a syndrome in which colorectal polyps have a characteristic gear morphology. In a study published in the journal Gut, researchers have confirmed that this syndrome predisposes to colon cancer but with a lower risk than the previously published. Dr. Francesc Balaguer, head of the High Risk Colorectal Cancer Unit at Hospital Clínic of Barcelona and researcher at the Gastrointestinal and pancreatic oncology IDIBAPS team, has coordinated this study. The first author of the paper is Dr. Sabela Carballal, specialist at the Gastroenterology Department at Hospital Clinic.

Read the rest of this entry »

Comments Closed

Categories

Posted in:

Wednesday June 19th, 2013

Dr. Eduard Batlle explains the complexities of Colorectal Cancer in an IDIBAPS Seminar

Colorectal Cancer (CRC) is one of the leading causes of death by cancer worldwide. Dr. Eduard Batlle leads the Oncology Program and the Colorectal Cancer Laboratory at the Barcelona’s Institute for Research in Biomedicine (IRB), where they study the initiation of CRC and its progression from the early stages to the formation of invasive tumors. On Monday June 17th he offered an IDIBAPS Seminar titled “Understanding Colorectal Cancer as a Stem Cell hierarchy”. The Seminar was presented by Dr. Cristina Nadal, IDIBAPS investigator at the Molecular and translational oncology team that collaborated with Dr. Batlle in some of the results he presented. The Seminar turned out to be one of the recent sessions with the highest participation from the audience.

Read the rest of this entry »

Comments Closed